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Background: Colonoscopy offers limited protection against right-sided colon cancer, a significant proportion of
which arise from the serrated pathway of carcinogenesis. The aim of this study was to compare cap-assisted
colonoscopy and standard high-definition white light colonoscopy regarding serrated polyps’ detection.
Methods: Post hoc analysis was performed of a previously conducted randomized controlled trial comparing
standard and cap-assisted colonoscopy for adenoma detection. Randomization was stratified based on the
indication of colonoscopy and all procedures were performed by three experienced endoscopists. Following cecal
intubation, the colonic mucosa was carefully inspected during withdrawal of colonoscope and all polyps detected
were documented for their size, location, morphology and then removed and sent for histopathology. Detection
rates of significant serrated polyps between both arms were compared using the Fisher’s exact test and Wilcoxon
Rank Sum test.
Results: 427 patients were enrolled (7 exclusions, 210 completed study in each arm, mean age of 61 years, 95%
male, 75% Caucasian, 67% screening colonoscopies). There were no significant differences in baseline characteristics
between both groups. Cap-assisted colonoscopy detected a significantly higher proportion of subjects with
significant serrated polyps as well as a higher total number of significant serrated polyps compared to standard
colonoscopy (12.8% vs. 6.6%, p =0.047 and 40 vs. 20,p = 0.03 respectively).
Conclusions: In this post-hoc analysis, Cap-assisted colonoscopy is a safe technique that offers a higher detection
rate of significant serrated polyps when compared to standard colonoscopy. If confirmed in future trials, this simple
technique has the potential to improve protection against interval colon cancers.
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Colonoscopy is one of the recommended screening tests
for colorectal cancer (CRC) in the US. The added benefit
of colonoscopy in preventing CRC makes it the pre-
ferred modality compared to the other screening tests
[1]. The basic mechanism by which colonoscopy pre-
vents CRC is by the detection and removal of adenomas
that are the precursor lesions for cancer [2]. However,
the magnitude of CRC protection has been shown in
multiple studies to be site dependent (proximal vs distal
colon) with proximal (right sided) CRC protection being
less pronounced [3,4]. The factors accounting for this
lower protection against proximal CRC have been a* Correspondence: arastogi@kumc.edu
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unless otherwise stated.matter of debate with multiple potential explanations
put forth by investigators. One such explanation is the
presence of serrated lesions in the right colon and the
inability to detect them during colonoscopy resulting in
a higher incidence of interval colon cancer in the prox-
imal colon [5] through the serrated pathway of colorec-
tal carcinogenesis.
As per the latest WHO classification, serrated polyps
are classified into three categories; hyperplastic polyps,
sessile serrated adenoma/polyps, and traditional serrated
adenomas [6]. These polyps possess variable endoscopic
and histopathologic features [7] as well as variable ma-
lignant potential [8]. These lesions are subtle and non
polypoid (flat) making them susceptible to being missed
during colonoscopy [9]. Studies have shown that there is
a wide variation in the detection of proximal serratedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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that these polyps are being missed during colonoscopy
and maybe even more so than adenomas [10] and also
associated with higher rates of incomplete resection
[11]. Therefore improving proximal serrated polyp de-
tection rate is being recognized as an important goal
that may improve the protection afforded by colonos-
copy against right sided colon cancer [12].
Multiple strategies have been evaluated to improve the
polyp/adenoma detection rate during colonoscopy [13].
Cap assisted colonoscopy (CAC) is one such technique
that has been investigated and shown to be safe with
some benefit in improving the polyp/adenoma detection
rates [14]. However, CAC has not been well studied for
the detection of serrated polyps although a recent ran-
domized controlled study comparing adenoma detection
between conventional colonoscopy and CAC has pro-
vided a subgroup analysis for the detection of serrated
polyps with no difference between the two arms [15].
The aim of this study was to compare the detection of
significant serrated polyps [sessile serrated adenoma/
polyp, traditional serrated adenoma, proximal hyperplas-
tic polyps and large (≥1 cm) hyperplastic polyp] between
CAC and standard colonoscopy.
Methods
Study design
We conducted a post hoc analysis of a previously con-
ducted randomized controlled trial comparing standard
(SC) and cap assisted colonoscopy (CAC) for adenoma
detection [14]. The original study was a prospective ran-
domized controlled trial conducted at the Kansas City
Veterans Affairs Medical Center and was approved by
its Institutional Review Board (KCVA IRB) and was reg-
istered at http://clinicaltrial.gov (NCT 01211132). The
primary results have been previously reported [16].
Study subjects
Subjects who were referred for screening or surveil-
lance colonoscopy were prospectively enrolled between
September 2009 and October 2010. Subjects were in-
cluded in the study if they were referred for a screening
or surveillance colonoscopy and agreed to provide a
written informed consent. The procedure was considered
a screening one if the patient never had a colonoscopy be-
fore or if no polyps were detected on previous colonos-
copies. On the other hand, subjects with a history of
adenoma on a prior colonoscopy and who were referred
for follow-up were deemed to be undergoing surveillance
colonoscopy.
The exclusion criteria of the study included previous
surgical resection of any part of the colon, personal
history of colon cancer, history of inflammatory bowel
disease, use of antiplatelet agents or anti-coagulants thatprecluded removal of polyps, poor general condition or
any other reason to avoid prolonged procedure time,
history of polyposis syndrome or hereditary nonpolypo-
sis colorectal cancer, or the inability to give an informed
consent.
Following enrollment and randomization to one of the
arms, those subjects who had inadequate colon prepar-
ation or in whom the cecum could not be reached were
also excluded. Different patient parameters were recorded
included demographics (age, gender and race), indication
of colonoscopy, body mass index (BMI), family history of
colorectal cancer (first-degree relative), history of smok-
ing, and history of prior abdominal surgery.
Randomization
Following enrollment, subjects were randomized to
undergo either SC or CAC by opening an opaque
sealed envelope containing the procedure allocation.
The randomization sequence was stratified by the indi-
cation of colonoscopy (screening vs. surveillance) and
was generated by the statistician with a computerized
randomization scheme using block sizes of 10.
Colonoscopy procedure
Moderate sedation was used in the study using intraven-
ous midazolam in combination with either meperidine
or fentanyl. The colonoscope was inserted and advanced
to the cecum. Careful mucosal inspection and polypec-
tomies were performed during the withdrawal phase.
Procedural times were recorded using a stopwatch (the
cecal intubation time as well as withdrawal time). The
stopwatch was not paused during any maneuver intended
to assist cecal intubation (like suctioning of fluid, cleaning
of the mucosa, abdominal pressure, or changing of pos-
ition). The cecum was identified using the landmarks
including the appendiceal orifice (which was photo doc-
umented) and intubation of the terminal ileum was
attempted in all cases and its successful intubation was
recorded. The withdrawal time in the study was defined
as the time spent on mucosal inspection while the
colonoscope was being withdrawn. The stopwatch was
paused whenever the colonic mucosa was not being
examined (for example during suctioning of fluid or
during biopsies and polypectomy). In the CAC proce-
dures, the cap was used to flatten the mucosal folds in
order to inspect their proximal aspect for polyps.
Bowel preparation was evaluated and was then classified
into four categories [17] as follows: excellent (>90% of
mucosa seen, the colonic contents were mostly liquid with
minimal suctioning needed for clearing the mucosa), good
(same as excellent except that significant suctioning was
needed for clearing the mucosa), fair same as excellent ex-
cept that the colonic contents were a mixture of liquid
and semisolid which could be suctioned and/or washed),
Table 1 Significant serrated polyps’ detection
SC CAC P value
N = 210 N = 210
Total Number of Significant Serrated Polyp 20 40 0.032
Total Number of Proximal Hyperplastic Polyp 14 26 0.10
Total Number of Large Hyperplastic Polyps 7 12 0.19
Total Number of SSA or TSA 1 7 0.03
Rzouq et al. BMC Gastroenterology  (2015) 15:11 Page 3 of 5and inadequate (<90% of mucosa seen, the colonic con-
tents were a mixture of semisolid and solid colonic con-
tents, which could not be suctioned or washed). All
procedural complications were recorded (like bleeding or
perforation). Endoscopists were asked to document any
technical difficult encountered with the cap like cap dis-
lodgement or any difficulty in suctioning fluid or cleaning
the mucosa or during therapeutic interventions attribut-
able to the cap.
Study endpoints and statistical analysis
All analyses were performed using Stata/IC V.10.1
(StataCorp). The original study was powered to the pri-
mary end point that was the proportion of subjects
with at least one adenoma. Fisher’s exact test, t test,
and Wilcoxon rank sum test were used to compare the
differences across the two study groups regarding the
total number of subjects with significant serrated polyps
as well as the total number of significant serrated polyps
detected. Similar comparisons were made for the indi-
vidual categories of serrated polyps. A p value <0.05 was
considered statistically significant and the results were
reported in accordance to the guidelines of CONSORT
2010 [18] and Standards for Reporting of Diagnostic
Accuracy [19].
Definitions
Significant serrated polyps were defined in this study as
sessile serrated adenoma/polyp, traditional serrated ad-
enoma, proximal hyperplastic polyps and large (≥1 cm)
hyperplastic polyp.
Pathology review
All specimens were reviewed by an expert GI-pathologist
who is well-familiar with the recent WHO classification
for serrated polyposis.
Results
Subjects and procedural characteristics
A total of 427 subjects were prospectively enrolled by 3
endoscopists in this randomized controlled trial between
September 2009 and October 2010. Seven subjects were
excluded (five due to failed cecal intubation, one due to
inadequate bowel preparation, and one due to the diag-
nosis of Crohn’s disease). Thus, a total of 420 patients
(210 in each of the two arms) completed the study
protocol (mean age of 61 years, 95% male, 75% Caucasian,
67% screening colonoscopies, 33% surveillance colonos-
copies). Baseline characteristics of subjects in both study
arms were similar like age, gender, race, smoking history,
BMI, and family history of colon cancer. Successful cecal
intubation was seen in the vast majority of cases (98% of
procedures in the SC group as compared to 99% in the
CAC group with p = 0.37). The mean insertion time wassignificantly shorter in the CAC group as compared to
the SC group (3.29 +/− 2.55 min vs. 3.98 +/− 2.56 min,
p < 0.001) and the terminal ileal intubation rate was
higher in the CAC group (91% vs. 83%, p 0.018). On
the other hand, the mean withdrawal time (5.95 ± 1.58
min in CAC vs 5.98 ± 1.45 min for standard colonoscopy,
p = 0.75), bowel preparation quality, and sedation medica-
tion doses were not significantly different between the two
groups.
Serrated polyps detection rate
As outlined in Table 1, CAC detected higher total num-
ber of significant serrated polyps when compared to SC
(40 vs 20; P 0.032). For subgroup analysis, CAC detected
a higher number of SSA/P or TSA (7 vs 1, p 0.03). Al-
though the number of proximal hyperplastic polyps (26 vs
14; P 0.1) and large hyperplastic polyps (12 vs 7; P 0.19)
was numerically higher with CAC, the differences did not
achieve statistical significance.
Similarly, the proportion of subjects with significant
serrated polyps was higher in the CAC as compared to
the SC group (13% vs 7%; P 0.047). For the subgroup
analysis, the proportion of subjects with SSA/SSP or
TSA, proximal HP, large HP, were numerically higher in
the CAC compared to SC but these differences did not
reach statistical significance for any subgroup (Table 2).
Discussion
Our knowledge about serrated polyps continues to
evolve. The recent WHO classification divided them into
3 categories: hyperplastic polyps, sessile serrated aden-
oma/polyps, and traditional serrated adenomas [6].
While previously all hyperplastic polyps were consid-
ered to have no malignant potential [20], there has
been a recent shift in the understanding. Expert con-
sensus has deemed proximal hyperplastic polyps to be
of some neoplastic potential contrary to what was pre-
viously thought [21]. Moreover, serrated polyps in the
proximal colon may have been misclassified as hyper-
plastic subtype by the pathologists to begin with [22].
Along with this multiple studies have shown that there
is marked variability amongst the pathologists in dif-
ferentiating between hyperplastic polyps and SSA/P
[23,24]. As a result in this study we included proximal
and large hyperplastic polyps along with SSA/P and
Table 2 Proportion of subjects with significant serrated
polyps
SC CAC P value
N = 210 N = 210
Significant Serrated Polyp (%) 14 (7%) 27 (13%) 0.047
Proximal Hyperplastic Polyp (%) 12 (6%) 21 (10%) 0.15
Large Hyperplastic Polyps (%) 5 (2%) 10 (5%) 0.29
SSA or TSA (%) 1 (0.5%) 7 (3%) 0.07
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recognizing their malignant potential.
CAC can serve as a simple technique to help examine
the mucosa on the proximal aspects of colonic. After
application on to the tip of the colonoscope, the cap
protrudes for about 4 mm. This portion helps to flatten
the colonic folds and brings the mucosa on their prox-
imal aspects in the view of the endoscopist. In the pri-
mary results of this study reported earlier, we showed
that CAC significantly improved the adenoma detection
rates [16] while other studies have showed varying re-
sults with CAC [14].
We herein report the results of a post hoc analysis of a
previously published randomized controlled trial com-
paring CAC and standard colonoscopy [16]. We found
that CAC showed a significantly higher detection rate
for significant serrated polyps and also for the propor-
tion of subjects who had at least one significant serrated
polyp. The comparisons for the subtypes of serrated
polyps did not show a significant difference except for
the total number of SSA/TSA that was significantly
higher for the CAC group. The other subcategories were
numerically higher for CAC and the lack of statistical
significance could very well be explained by a Type II
error, as the trial was not powered adequately to detect a
difference in these categories. Future randomized con-
trolled trials specifically powered to detect a difference
in the detection of serrated polyps between CAC and
standard colonoscopy are warranted. Moreover, whether
this improved detection of serrated polyps by CAC has
any positive impact on the future development of prox-
imal CRC will need further assessment by longer term
follow up studies.
The major appeal of CAC lies in the fact that it is a
relatively inexpensive technology that is easy to use and
safe. Other methods to examine the proximal aspect of
folds involve third eye retroscope [25], retroflexion of
the colonoscope in the right colon [26] and recently
available wide angle colonoscopes [27]. The third eye
retroscope is expensive and relatively more cumbersome
to use as it needs to be removed after a polyp is detected
and then reinserted after polypectomy. Retroflexion in
the right colon is not widely practiced and in one study,
a second exam of the proximal colon in retroflexion didnot show superior polyp detection compared to a second
standard exam [28]. The extra wide angle colonoscope
that has a 330 degree angle of view has just recently be-
come available. Although preliminary studies have been
encouraging [29], more data from multiple centers is
awaited. It remains to say that other inexpensive and
safe technologies exist to examine behind folds like the
endocuff. The importance of evaluating and implement-
ing new strategies to improve the detection of serrated
polyps is related to the fact that this group of polyps has
a rather subtle appearance and non-polypoid morph-
ology making them susceptible to be missed during col-
onoscopy. This was shown in a recent study in which
there was a very wide variability in the detection rates
for proximal serrated polyps amongst endoscopists prac-
ticing in a single institution [10]. Furthermore, due to
their subtle appearance, serrated polyps are also more
likely to be incompletely resected compared to aden-
omatous polyps of same size, location, and morphology
[11]. This can also have implications for the develop-
ment of interval colon cancer as a result of incomplete
polypectomy.
The major strength of this study relies in the fact that
serrated polyposis is a significant source for colorectal
cancer and CAC is a safe and cheap technique that may
significantly improve the detection of these polyps and
help boost colonoscopy protection against colorectal
cancer development.
However, our study has several limitations. First, the
study was performed in an academic setting by three
experienced endoscopists and thus it remains unclear
if these results can be generalized to the community
endoscopists. Second, the original study was not pow-
ered to detect a difference in the detection of serrated
polyps. This raises the possibility of a Type II error as
an explanation for the lack of statistical significance in
the differences seen in the detection of the serrated
polyps subtypes between the two arms. Third, the majority
of patients enrolled in the study were male veterans and
Caucasians and the results may not be generalizable to the
general population. Fourth, as a consequence of the study
design (post-hoc analysis), the distal small hyperplastic
polyps were not removed during colonoscopy. Fifth, our
mean withdrawal time was less than 6 minutes for both
groups (although was not different between the two
groups). Finally, the presence of investigator bias remains
as issue in endoscopic studies such as this one since the
endoscopists cannot be blinded to the technology that is
being compared to the standard colonoscopy.
Conclusions
In conclusion, we have shown by a post hoc analysis of a
randomized controlled trial that CAC detects a higher
total number of significant serrated polyps as well as
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compared to standard colonoscopy. CAC is a safe, prac-
tical and easy to use method to improve the detection of
these clinically significant polyps. Further studies specific-
ally powered and aimed to compare the detection of the
specific sub types of serrated polyps between CAC and
standard colonoscopy are warranted.
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